Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.
Dr. James McCaffrey presents a complete end-to-end demonstration of anomaly detection using k-means data clustering, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback